16 research outputs found
HighâSaturatedâFat Diet Increases Circulating AngiotensinâConverting Enzyme, Which Is Enhanced by the rs4343 Polymorphism Defining Persons at Risk of NutrientâDependent Increases of Blood Pressure
Background Angiotensinâconverting enzyme (ACE) plays a major role in blood
pressure regulation and cardiovascular homeostasis. Contrary to the assumption
that ACE levels are stable, circulating ACE has been shown to be altered in
obesity and weight loss. We sought to examine effects of a highâsaturatedâfat
(HF) diet on ACE within the NUtriGenomic Analysis in Twins (NUGAT) study.
Methods and Results Fortyâsix healthy and nonobese twin pairs initially
consumed a carbohydrateârich, lowâfat diet over a period of 6 weeks to
standardize for nutritional behavior prior to the study, followed by 6 weeks
of HF diet under isocaloric conditions. After 6 weeks of HF diet, circulating
ACE concentrations increased by 15% (P=1.6Ă10â30), accompanied by an increased
ACE gene expression in adipose tissue (P=3.8Ă10â6). Stratification by ACE
rs4343, a proxy for the ACE insertion/deletion polymorphism (I/D), revealed
that homozygous carriers (GG) of the variant had higher baseline ACE
concentrations (P=7.5Ă10â8) and additionally showed a 2âfold increase in ACE
concentrations in response to the HF diet as compared to nonâ or heterozygous
carriers (AA/AG, P=2Ă10â6). GG carriers also responded with higher systolic
blood pressure as compared to AA/AG carriers (P=0.008). The strong geneâdiet
interaction was confirmed in a second independent, crossâsectional cohort, the
Metabolic Syndrome Berlin Potsdam (MeSyBePo) study. Conclusions The
HFâdietâinduced increase of ACE serum concentrations reveals ACE to be a
potential molecular link between dietary fat intake and hypertension and
cardiovascular disease (CVD). The GG genotype of the ACE rs4343 polymorphism
represents a robust nutrigenetic marker for an unfavorable response to
highâsaturatedâfat diets. Clinical Trial Registration URL:
http://www.clinicaltrials.gov. Unique identifier: NCT01631123
An Isocaloric High-Fat Diet Regulates Partially Genetically Determined Fatty Acid and Carbohydrate Uptake and Metabolism in Subcutaneous Adipose Tissue of Lean Adult Twins
Background: The dysfunction of energy metabolism in white adipose tissue (WAT) induces adiposity. Obesogenic diets that are high in saturated fat disturb nutrient metabolism in adipocytes. This study investigated the effect of an isocaloric high-fat diet without the confounding effects of weight gain on the gene expression of fatty acid and carbohydrate transport and metabolism and its genetic inheritance in subcutaneous (s.c.) WAT of healthy human twins. Methods: Forty-six healthy pairs of twins (34 monozygotic, 12 dizygotic) received an isocaloric carbohydrate-rich diet (55% carbohydrates, 30% fat, 15% protein; LF) for 6 weeks followed by an isocaloric diet rich in saturated fat (40% carbohydrates, 45% fat, 15% protein; HF) for another 6 weeks. Results: Gene expression analysis of s.c. WAT revealed that fatty acid transport was reduced after one week of the HF diet, which persisted throughout the study and was not inherited, whereas intracellular metabolism was decreased after six weeks and inherited. An increased inherited gene expression of fructose transport was observed after one and six weeks, potentially leading to increased de novo lipogenesis. Conclusion: An isocaloric dietary increase of fat induced a tightly orchestrated, partially inherited network of genes responsible for fatty acid and carbohydrate transport and metabolism in human s.c. WAT
IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling
Activation of endoplasmic reticulum (ER) stress/the unfolded protein response (UPR) has been linked to cancer, but the molecular mechanisms are poorly understood and there is a paucity of reagents to translate this for cancer therapy. Here, we report that an IRE1α RNase-specific inhibitor, MKC8866, strongly inhibits prostate cancer (PCa) tumor growth as monotherapy in multiple preclinical models in mice and shows synergistic antitumor effects with current PCa drugs. Interestingly, global transcriptomic analysis reveal that IRE1α-XBP1s pathway activity is required for c-MYC signaling, one of the most highly activated oncogenic pathways in PCa. XBP1s is necessary for optimal c-MYC mRNA and protein expression, establishing, for the first time, a direct link between UPR and oncogene activation. In addition, an XBP1-specific gene expression signature is strongly associated with PCa prognosis. Our data establish IRE1α-XBP1s signaling as a central pathway in PCa and indicate that its targeting may offer novel treatment strategies.</p
Bioinformatische Analyse der NUGAT-Studie (NUtriGenomic Analysis in Twins)
Frahnow T. Bioinformatische Analyse der NUGAT-Studie (NUtriGenomic Analysis in Twins). Potsdam: UniversitÀt Potsdam; 2016.Dissertation der UniversitÀt Potsdam, 201
Plasminogen Activator Inhibitor-1 is Regulated Through Dietary Fat Intake and Heritability: Studies in Twins
Engstler AJ, Frahnow T, Kruse M, Pfeiffer AFH, Bergheim I. Plasminogen Activator Inhibitor-1 is Regulated Through Dietary Fat Intake and Heritability: Studies in Twins. Twin Research and Human Genetics. 2017;20(04):338-348
Heritability and responses to high fat diet of plasma lipidomics in a twin study
Frahnow T, Osterhoff MA, Hornemann S, et al. Heritability and responses to high fat diet of plasma lipidomics in a twin study. Scientific Reports. 2017;7(1): 3750
An Isocaloric High-Fat Diet Regulates Partially Genetically Determined Fatty Acid and Carbohydrate Uptake and Metabolism in Subcutaneous Adipose Tissue of Lean Adult Twins
Background: The dysfunction of energy metabolism in white adipose tissue (WAT) induces adiposity. Obesogenic diets that are high in saturated fat disturb nutrient metabolism in adipocytes. This study investigated the effect of an isocaloric high-fat diet without the confounding effects of weight gain on the gene expression of fatty acid and carbohydrate transport and metabolism and its genetic inheritance in subcutaneous (s.c.) WAT of healthy human twins. Methods: Forty-six healthy pairs of twins (34 monozygotic, 12 dizygotic) received an isocaloric carbohydrate-rich diet (55% carbohydrates, 30% fat, 15% protein; LF) for 6 weeks followed by an isocaloric diet rich in saturated fat (40% carbohydrates, 45% fat, 15% protein; HF) for another 6 weeks. Results: Gene expression analysis of s.c. WAT revealed that fatty acid transport was reduced after one week of the HF diet, which persisted throughout the study and was not inherited, whereas intracellular metabolism was decreased after six weeks and inherited. An increased inherited gene expression of fructose transport was observed after one and six weeks, potentially leading to increased de novo lipogenesis. Conclusion: An isocaloric dietary increase of fat induced a tightly orchestrated, partially inherited network of genes responsible for fatty acid and carbohydrate transport and metabolism in human s.c. WAT
HighâSaturatedâFat Diet Increases Circulating AngiotensinâConverting Enzyme, Which Is Enhanced by the rs4343 Polymorphism Defining Persons at Risk of NutrientâDependent Increases of Blood Pressure
SchĂŒler R, Osterhoff MA, Frahnow T, et al. HighâSaturatedâFat Diet Increases Circulating AngiotensinâConverting Enzyme, Which Is Enhanced by the rs4343 Polymorphism Defining Persons at Risk of NutrientâDependent Increases of Blood Pressure. Journal of the American Heart Association. 2017;6(1): e004465
Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes
SchĂŒler R, Osterhoff MA, Frahnow T, et al. Dietary Fat Intake Modulates Effects of a Frequent ACE Gene Variant on Glucose Tolerance with association to Type 2 Diabetes. Scientific Reports. 2017;7(1): 9234
VEGF and GLUT1 are highly heritable, inversely correlated and affected by dietary fat intake: Consequences for cognitive function in humans
Objective: Reduction of brain glucose transporter GLUT1 results in severe neurological dysfunction. VEGF is required to restore and maintain brain glucose uptake across the blood brain barrier via GLUT1, which was shown to be acutely diminished in response to a high fat diet (HFD) in mice. The genetic and HFD-related regulation and association of VEGF and GLUT1 (SLC2A1) in humans was investigated in the NUtriGenomic Analysis in Twins (NUGAT) study. Methods: 92 healthy and non-obese twins were standardized to a high-carbohydrate low-fat diet for 6 weeks before switched to a 6-week HFD under isocaloric conditions. Three clinical investigation days were conducted: after 6 weeks of low-fat diet and after 1 and 6 weeks of HFD. Serum VEGF and other cytokine levels were measured using ELISA. Gene expression in subcutaneous adipose tissue was assessed by quantitative Real-Time PCR. Genotyping was performed using microarray. The Auditory Verbal Learning Task was conducted to measure cognitive performance. Results: In this human study, we showed that the environmental regulation of SLC2A1 expression and serum VEGF by HFD was inversely correlated and both factors showed strong heritability (>90%). In response to the HFD containing 45% fat, serum VEGF levels increased (P = 0.002) while SLC2A1 mRNA expression in adipose tissue decreased (P = 0.001). Higher BMI was additionally associated with lower SLC2A1 expression. AA-genotypes of the rs9472159 polymorphism, which explained similar to 39% of the variation in circulating VEGF concentrations, showed significantly reduced serum VEGF levels (P = 6.4 x 10(-11)) but higher SLC2A1 expression (P = 0.009) in adipose tissue compared to CC/CAgenotypes after 6 weeks of HFD. Memory performance in AA-genotypes declined in response to the HFD compared to CC-and CA-genotypes. Conclusions: The results provide evidence to suggest the translatability of the dietary regulation of VEGF and GLUT1 from mouse models to humans. Our data demonstrate that HFD induces a genetically determined and correlated decrease of GLUT1 and increase of VEGF which may affect memory performance. (C) 2018 The Authors. Published by Elsevier GmbH